相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。M2 Muscarinic Receptor Activation Impairs Mitotic Progression and Bipolar Mitotic Spindle Formation in Human Glioblastoma Cell Lines
Maria Di Bari et al.
CELLS (2021)
The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells
Claudia Guerriero et al.
CELLS (2021)
Cross Interaction between M2 Muscarinic Receptor and Notch1/EGFR Pathway in Human Glioblastoma Cancer Stem Cells: Effects on Cell Cycle Progression and Survival
Ilaria Cristofaro et al.
CELLS (2020)
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype
Alejandro J. Espanol et al.
PLOS ONE (2020)
Functional Characterization of Cholinergic Receptors in Melanoma Cells
Anna Maria Luciano et al.
CANCERS (2020)
The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells
Anna Maria Luciano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
M2 muscarinic receptor activation inhibits cell proliferation and migration of rat adipose-mesenchymal stem cells
Roberta Piovesana et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Activation of M2 muscarinic acetylcholine receptors by a hybrid agonist enhances cytotoxic effects in GB7 glioblastoma cancer stem cells
Ilaria Cristofaro et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
BCL-XL overexpression promotes tumor progression-associated properties
Daniela Trisciuoglio et al.
CELL DEATH & DISEASE (2017)
The activation of M2 muscarinic receptor inhibits cell growth and survival in human glioblastoma cancer stem cells
Francesco Alessandrini et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells
Maria Di Bari et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells
Luca Pacini et al.
CANCER BIOLOGY & THERAPY (2014)
Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases
Lik Hang Lee et al.
SCIENTIFIC REPORTS (2014)
p53 in breast cancer subtypes and new insights into response to chemotherapy
Philippe Bertheau et al.
BREAST (2013)
M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells
Michela Ferretti et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
An Antimitotic and Antivascular Agent BPR0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-Resistant Ovarian Cancer Cells
Xiaolei Wang et al.
PLOS ONE (2013)
Gonadotropin signalling in epithelial ovarian cancer
Inga Mertens-Walker et al.
CANCER LETTERS (2012)
M2 muscarinic receptors inhibit cell proliferation in human glioblastoma cell lines
M. Ferretti et al.
LIFE SCIENCES (2012)
Regulation of airway inflammation and remodeling by muscarinic receptors: Perspectives on anticholinergic therapy in asthma and COPD
Loes E. M. Kistemaker et al.
LIFE SCIENCES (2012)
Bcl2 family proteins in carcinogenesis and the treatment of cancer
Anna Frenzel et al.
APOPTOSIS (2009)
DNA damage induces two distinct modes of cell death in ovarian carcinomas
H. Vakifahmetoglu et al.
CELL DEATH AND DIFFERENTIATION (2008)
Bcl-xL blocks high dose doxorubicin-induced apoptosis but not low dose doxorubicin-induced cell death through mitotic catastrophe
Seok Soon Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Acetylcholine inhibits cell cycle progression in rat Schwann cells by activation of the M2 receptor subtype
Simona Loreti et al.
NEURON GLIA BIOLOGY (2007)
Endocrine signaling in ovarian surface epithelium and cancer
Peter C. K. Leung et al.
HUMAN REPRODUCTION UPDATE (2007)
A non-neuronal cholinergic system of the ovarian follicle
A Mayerhofer et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2005)
Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas
O Gubbay et al.
BRITISH JOURNAL OF CANCER (2005)
Cell death by mitotic catastrophe: a molecular definition
M Castedo et al.
ONCOGENE (2004)
Luteinizing hormone in peritoneal and ovarian cyst fluids: a predictor of ovarian carcinoma
R Halperin et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2003)
Ovarian acetylcholine and muscarinic receptors: Hints of a novel intrinsic ovarian regulatory system
A Mayerhofer et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2002)
Muscarinic receptors in cell lines from ovarian carcinoma:: Negative correlation with survival of patients
M Oppitz et al.
GYNECOLOGIC ONCOLOGY (2002)
If not apoptosis, then what? - Treatment-induced senescence and mitotic catastrophe in tumor cells
IB Roninson et al.
DRUG RESISTANCE UPDATES (2001)
Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer
JA Parrott et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer
JA Parrott et al.
BIOLOGY OF REPRODUCTION (2000)
Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer
JA Parrott et al.
BIOLOGY OF REPRODUCTION (2000)
分享论文
